GLP-1 Receptor Agonists (eg, Semaglutide) Diabetes Pharmacology Review

Understand the GLP-1 receptor agonists—and why agents like semaglutide (Ozempic/Wegovy/Rybelsus), liraglutide, dulaglutide, and exenatide have become one of the most talked-about type 2 diabetes medications in modern practice. In this lecture from This is Why, Dr. Busti will break GLP-1s down in a clear, clinically relevant way so you can confidently explain how they work, when to use them, and what to watch for clinically when managing patients with type 2 diabetes and/or obesity.You’ll learn how to:- Mechanism of action: incretin mimetic effects (GLP-1) and what that means for glucose control- Therapeutic use: where GLP-1 agonists fit in type 2 diabetes (T2DM) treatment strategies- Key agents: semaglutide, plus comparisons to liraglutide, dulaglutide, and exenatide- Benefits & counseling pearls: weight effects, dosing basics, and practical patient education- Adverse effects & precautions: the high-yield safety points clinicians get tested on (and seen in clinical practice)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/glp-1-receptor-agonists-semaglutide-dulaglutide-liraglutide-diabetes-pharmacology-reviewGet more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#glp1receptoragonist #semaglutide #type2diabetes #diabetesmedications #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.